Skip to content
Recall Observatory FDA recall evidence

Drug product

Enablex (darifenacin) Extended Release Tablet, 15 mg per tablet. Physician Sample 7 Tablets bottle, Rx only, Mfd by: Novartis Pharma Stein AG, Stein, Switzerland, NDC 0078-9420-07

D-822-2013

May 17, 2013

Class II

Product summary

Firm
Warner Chilcott US LLC
Event
Event 65461
Status
Terminated
Classification
Class II
Quantity
188,600 bottles
Official record key
drug-enforcement:D-822-2013

Official wording

Reason: Failed Impurities/Degradation Specifications: unspecified degradation product

Code information: Lot F1002 - Exp.12/13

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications